| Q35744505 | (111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents |
| Q41251561 | Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma |
| Q91393222 | Clinical utility of 177 Lu-DOTATATE PRRT in somatostatin receptor-positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity |
| Q43296875 | Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma |
| Q44407841 | Differential somatostatin receptor subtype expression in human normal pineal gland and pineal parenchymal tumors |
| Q39454856 | Dual functional octreotide-modified liposomal irinotecan leads to high therapeutic efficacy for medullary thyroid carcinoma xenografts |
| Q46568255 | Expression of hypothalamic regulatory peptides in thyroid C cells of different mammals |
| Q37107084 | Expression of somatostatin receptor subtypes in human thyroid tumors: the immunohistochemical and molecular biology (RT-PCR) investigation |
| Q35769837 | Mapping of somatostatin receptor types in GH or/and PRL producing pituitary adenomas |
| Q27005897 | Medical management of metastatic medullary thyroid cancer |
| Q38046525 | Medullary thyroid cancer--current treatment strategy, novel therapies and perspectives for the future |
| Q38171726 | Medullary thyroid carcinoma: a 25-year perspective |
| Q41844515 | Mixed medullary and follicular carcinoma of the thyroid. On the search for its histogenesis |
| Q48098904 | Molecular imaging of advanced thyroid cancer: iodinated radiotracers and beyond. |
| Q89002621 | Multikinase Inhibitors for the Treatment of Progressive, Metastatic Medullary Thyroid Cancer - An Evolving Paradigm |
| Q62863996 | Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism |
| Q40844566 | Multiple regulation of adenylyl cyclase activity by G-protein coupled receptors in human foetal lung fibroblasts |
| Q59074896 | PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors |
| Q34468665 | Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma |
| Q43876300 | Routine preoperative (111)In-octreotide scintigraphy in patients with medullary thyroid cancer |
| Q44192910 | Somatostatin analogs in the treatment of medullary thyroid carcinoma |
| Q48289865 | Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma |
| Q36024996 | Somatostatin receptors and their interest in diagnostic pathology |
| Q38889681 | The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells |